Neuphoria Therapeutics, Inc. (NEUP)
3.73
0.00 (0.00%)
USD |
NASDAQ |
Sep 11, 16:00
3.74
+0.01
(+0.27%)
After-Hours: 20:00
Neuphoria Therapeutics Price to Book Value : 0.6817 for Sept. 11, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 0.6817 |
| September 10, 2026 | 0.6817 |
| September 09, 2026 | 0.6853 |
| September 08, 2026 | 0.6853 |
| September 04, 2026 | 0.689 |
| September 03, 2026 | 0.6872 |
| September 02, 2026 | 0.6853 |
| September 01, 2026 | 0.6926 |
| August 31, 2026 | 0.6872 |
| August 28, 2026 | 0.6872 |
| August 27, 2026 | 0.689 |
| August 26, 2026 | 0.7054 |
| August 25, 2026 | 0.7054 |
| August 24, 2026 | 0.7219 |
| August 21, 2026 | 0.7146 |
| August 20, 2026 | 0.7219 |
| August 19, 2026 | 0.7182 |
| August 18, 2026 | 0.7274 |
| August 17, 2026 | 0.7036 |
| August 14, 2026 | 0.7073 |
| August 13, 2026 | 0.6999 |
| August 12, 2026 | 0.6963 |
| August 11, 2026 | 0.6963 |
| August 10, 2026 | 0.7054 |
| August 07, 2026 | 0.6981 |
| Date | Value |
|---|---|
| August 06, 2026 | 0.7127 |
| August 05, 2026 | 0.7219 |
| August 04, 2026 | 0.7109 |
| August 03, 2026 | 0.7182 |
| July 31, 2026 | 0.7091 |
| July 30, 2026 | 0.7164 |
| July 29, 2026 | 0.6945 |
| July 28, 2026 | 0.6963 |
| July 27, 2026 | 0.7036 |
| July 24, 2026 | 0.6652 |
| July 23, 2026 | 0.7164 |
| July 22, 2026 | 0.6086 |
| July 21, 2026 | 0.6104 |
| July 20, 2026 | 0.6031 |
| July 17, 2026 | 0.6241 |
| July 16, 2026 | 0.6451 |
| July 15, 2026 | 0.6433 |
| July 14, 2026 | 0.6524 |
| July 13, 2026 | 0.6378 |
| July 10, 2026 | 0.6469 |
| July 09, 2026 | 0.6415 |
| July 08, 2026 | 0.6433 |
| July 07, 2026 | 0.6561 |
| July 06, 2026 | 0.6287 |
| July 02, 2026 | 0.6177 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Agenus, Inc. | -- |
| Amgen, Inc. | 17.45 |
| Anika Therapeutics, Inc. | 2.034 |
| BioCryst Pharmaceuticals, Inc. | -- |
| Imunon, Inc. | 1.637 |
Price to Book Value Related Metrics
| PE Ratio | 2.931 |
| PS Ratio | 0.8649 |
| Price | 3.73 |
| Earnings Yield | 34.12% |
| Market Cap | 20.06M |
| Operating PE Ratio | 5.567 |
| Normalized PE Ratio | 1.593 |